Jupiter Wellness’ JW-100 Enters Clinical Trial for the Treatment of Herpes
Marks Jupiter’s 3rd Clinical Indication Including Eczema and Burns Study Data to Be Used in Planned IND Filing With U.S. FDA JUPITER, FL / ACCESSWIRE / November 17, 2020 /Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has initiated an exploratory clinical study in […]